CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
Oncology Today with Dr Neil Love
00:00
High response rates with proteasome combos
Paul highlights striking responses (including ~80% with bortezomib) and rekindle study results with quadruplet regimens.
Play episode from 09:12
Transcript
